Department of Clinical Nutrition, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Gulou District, Nanjing, China.
Department of Radiology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Gulou District, 321 Zhongshan Road, Nanjing, China.
Lipids Health Dis. 2022 Oct 14;21(1):102. doi: 10.1186/s12944-022-01707-w.
Visceral obesity is associated with cancer incidence and prognosis. Altered lipid profiles are frequently seen in visceral obese patients. The blood test of lipid profiles is more convenient and has no radical side effects than computed tomography (CT), which is presently the most accurate way to measure visceral fat area. This article aims to investigate the associations between lipid profiles and visceral obesity in gastrointestinal cancer patients.
In total, 399 patients newly diagnosed with gastrointestinal cancer were enrolled in this observational study. Lipid profiles were obtained from blood samples, and visceral fat mass area (VFA) was measured by CT. VFA ≥ 100 cm was considered visceral obesity. The area under the receiver operating characteristic curve (AUROC) was utilized to evaluate the prognostic powers of lipid parameters for viscerally obese gastrointestinal cancer patients.
Patients who had visceral obesity had higher triglyceride (TG) levels (1.20 ± 0.60 vs. 0.87 ± 0.57 mmo/L, P < 0.001), total cholesterol (TC) levels (3.57 ± 0.84 vs. 3.40 ± 0.82, P = 0.044), and low-density lipoprotein (LDL-C) levels (2.08 ± 0.66 vs. 1.94 ± 0.66, P = 0.047) and lower high-density lipoprotein (HDL-C) levels (0.88 ± 0.24 vs. 1.00 ± 0.26, P < 0.001) than those in the normal group. TG was positively correlated with VFA (r = 0.299, P < 0.001), while HDL-C was inversely correlated with VFA (r = -0.237, P < 0.001). TG and HDL-C had predictive capacity for visceral obesity at cutoff levels of 0.92 mmol/L (AUROC 0.700, 95% CI, 0.653-0.745, P < 0.001) and 0.98 mmol/L (AUROC 0.700, 95% CI, 0.585-0.682, P < 0.001), respectively. TG > 0.92 mmol/L with HDL-C < 0.98 mmol/L was linked with an increased risk of visceral obesity (OR = 4.068, 95% CI, 2.338-7.079, P < 0.001).
Lipid profiles were significantly correlated with VFA. Gastrointestinal cancer patients with TG > 0.92 mmol/L and HDL-C < 0.98 mmol/L were at elevated risk of visceral obesity in the Chinese population. Identifying visceral obesity and taking proper actions in gastrointestinal cancers are helpful for overall tumor prognosis.
内脏肥胖与癌症的发病率和预后有关。内脏肥胖患者的血脂谱经常发生变化。血脂谱的血液检测比目前测量内脏脂肪面积最准确的方法 CT 更方便,且没有根治性的副作用。本文旨在探讨血脂谱与胃肠道癌症患者内脏肥胖之间的关系。
本观察性研究共纳入 399 名新诊断为胃肠道癌症的患者。从血液样本中获取血脂谱,并用 CT 测量内脏脂肪质量面积(VFA)。VFA≥100cm 被认为是内脏肥胖。利用受试者工作特征曲线下面积(AUROC)评估血脂参数对内脏肥胖胃肠道癌症患者的预后预测能力。
患有内脏肥胖的患者 TG 水平(1.20±0.60 比 0.87±0.57mmol/L,P<0.001)、TC 水平(3.57±0.84 比 3.40±0.82mmol/L,P=0.044)、LDL-C 水平(2.08±0.66 比 1.94±0.66mmol/L,P=0.047)更高,HDL-C 水平(0.88±0.24 比 1.00±0.26mmol/L,P<0.001)更低。TG 与 VFA 呈正相关(r=0.299,P<0.001),而 HDL-C 与 VFA 呈负相关(r=-0.237,P<0.001)。在截断值为 0.92mmol/L(AUROC 0.700,95%CI,0.653-0.745,P<0.001)和 0.98mmol/L(AUROC 0.700,95%CI,0.585-0.682,P<0.001)时,TG 和 HDL-C 对内脏肥胖有预测能力。TG>0.92mmol/L 且 HDL-C<0.98mmol/L 与内脏肥胖风险增加相关(OR=4.068,95%CI,2.338-7.079,P<0.001)。
血脂谱与 VFA 显著相关。中国人群中,TG>0.92mmol/L 且 HDL-C<0.98mmol/L 的胃肠道癌症患者内脏肥胖风险增加。识别内脏肥胖并在胃肠道癌症中采取适当措施有助于整体肿瘤预后。